AROI-ESTRO GYN Teaching Course

First page Table of contents Previous page 1230 Next page Last page

3 y-LC : 90%

3 y-morbidity ≥G3 : 10% 3% 3 y-OS : IGABT/ChTh : 79% NOCECA : 63%

GUSTAVE ROUSSY

THÈME DU DIAPORAMA

Lindegaard et al. Acta Oncologica 2013

Made with